Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis

Journal of Proteomics

Volumn 75, Issue 10, 2012, Pages 2960-2971

  de la Cuesta, Fernando ^a   Barderas, Maria G ^b   Calvo, Enrique ^c   Zubiri, Irene ^a   Maroto, Aroa S ^a   Darde, Veronica M ^b   Martin Rojas, Tatiana ^b   Gil Dones, Felix ^b   Posada Ayala, Maria ^a   Tejerina, Teresa ^d   Lopez, Juan A ^c   Vivanco, Fernando ^a,d   Alvarez Llamas, Gloria ^a  

^a UAM)   (Spain)

^b HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Atheroma plaque; Coronary artery; Secretome; Vascular disease

Indexed keywords

GELSOLIN; LAMIN A; LAMIN C; PHOSPHOGLUCOMUTASE; PROTEIN; SECRETOME; UNCLASSIFIED DRUG; VINCULIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BREAST; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; CORONARY VESSELS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84861339785     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.12.005     Document Type: Article

References (30)

1. Stastna M., Chimenti I., Marban E., Van Eyk J.E. Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics 2010, 10:245-253.
2. Stastna M., Abraham M.R., Van Eyk J.E. Cardiac stem/progenitor cells, secreted proteins, and proteomics. FEBS Lett 2009, 583:1800-1807.
3. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
4. Duran M.C., Mas S., Martin-Ventura J.L., Meilhac O., Michel J.B., Gallego-Delgado J., et al. Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 2003, 3:973-978.
5. Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., Meilhac O., Leclercq A., Michel J.B., et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110:2216-2219.
6. Martin-Ventura J.L., Tunon J., Duran M.C., Blanco-Colio L.M., Vivanco F., Egido J. Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients. J Am Soc Nephrol 2006, 17:S189-S193.
7. Delbosc S., Haloui M., Louedec L., Dupuis M., Cubizolles M., Podust V.N., et al. Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol Med 2008, 14:383-394.
8. Duran M.C., Martin-Ventura J.L., Mohammed S., Barderas M.G., Blanco-Colio L.M., Mas S., et al. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur J Pharmacol 2007, 562:119-129.
9. de la Cuesta F., Alvarez-Llamas G., Maroto A.S., Donado A., Zubiri I., Posada M., et al. A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol Cell Proteomics 2011, 10:M110.
10. You S.A., Archacki S.R., Angheloiu G., Moravec C.S., Rao S., Kinter M., et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics 2003, 13:25-30.
11. Bagnato C., Thumar J., Mayya V., Hwang S.I., Zebroski H., Claffey K.P., et al. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2007, 6:1088-1102.
12. de la Cuesta F., Alvarez-Llamas G., Maroto A.S., Donado A., Juarez-Tosina R., Rodriguez-Padial L., et al. An optimum method designed for 2-D DIGE analysis of human arterial intima and media layers isolated by laser microdissection. Proteomics Clin Appl 2009, 3:1174-1184.
13. Alvarez-Llamas G., Szalowska E., de Vries M.P., Weening D., Landman K., Hoek A., et al. Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 2007, 6:589-600.
14. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
15. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
16. Neilson K.A., Ali N.A., Muralidharan S., Mirzaei M., Mariani M., Assadourian G., et al. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011, 11:535-553.
17. Bendtsen J.D., Jensen L.J., Blom N., Von H.G., Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004, 17:349-356.
18. Welton J.L., Khanna S., Giles P.J., Brennan P., Brewis I.A., Staffurth J., et al. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics 2010, 9:1324-1338.
19. Gonzales P.A., Pisitkun T., Hoffert J.D., Tchapyjnikov D., Star R.A., Kleta R., et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009, 20:363-379.
20. Pisitkun T., Shen R.F., Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004, 101:13368-13373.
21. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010, 73:1907-1920.
22. Yamaoka-Tojo M., Ushio-Fukai M., Hilenski L., Dikalov S.I., Chen Y.E., Tojo T., et al. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ Res 2004, 95:276-283.
23. Ikeda S., Yamaoka-Tojo M., Hilenski L., Patrushev N.A., Anwar G.M., Quinn M.T., et al. IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol 2005, 25:2295-2300.
24. Ekmekci O.B., Ekmekci H. Vitronectin in atherosclerotic disease. Clin Chim Acta 2006, 368:77-83.
25. Lee W.M., Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992, 326:1335-1341.
26. Zemljic-Harpf A.E., Ponrartana S., Avalos R.T., Jordan M.C., Roos K.P., Dalton N.D., et al. Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy. Am J Pathol 2004, 165:1033-1044.
27. Al-Shali K.Z., Hegele R.A. Laminopathies and atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:1591-1595.
28. Ragnauth C.D., Warren D.T., Liu Y., McNair R., Tajsic T., Figg N., et al. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 2010, 121:2200-2210.
29. Smith S.C., Smith E.C., Gilman M.L., Anderson J.L., Taylor R.L. Differentially expressed soluble proteins in aortic cells from atherosclerosis-susceptible and resistant pigeons. Poult Sci 2008, 87:1328-1334.
30. Berhane B.T., Zong C., Liem D.A., Huang A., Le S., Edmondson R.D., et al. Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005, 5:3520-3530.